DexCom, Inc.
DXCM
株式のランク
#758
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
株価
$85.98
最終同期: 2026-10-16
時価総額
$32.45B
変化（1日）
-1.97%
変化（1年）
29.10%
国
US
取引 DexCom, Inc. (DXCM)
カテゴリー
Healthcare
DexCom, Inc.（DXCM）の営業利益率
October 2026 時点の営業利益率 TTM: 22.92%
DexCom, Inc. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 22.92% です。2023 年末時点では 16.50% でした。
DexCom, Inc. の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 22.92% | 54.03% |
| 2024 | 14.88% | -9.82% |
| 2023 | 16.50% | 22.77% |
| 2022 | 13.44% | 23.76% |
| 2021 | 10.86% | -30.12% |
| 2020 | 15.54% | 61.20% |
| 2019 | 9.64% | -153.38% |
| 2018 | -18.06% | 205.07% |
| 2017 | -5.92% | -46.91% |
| 2016 | -11.15% | -21.48% |
| 2015 | -14.20% | 71.29% |
| 2014 | -8.29% | -54.10% |
| 2013 | -18.06% | -67.61% |
| 2012 | -55.76% | -5.17% |
| 2011 | -58.80% | -36.86% |
| 2010 | -93.13% | -39.67% |
| 2009 | -154.36% | -71.25% |
| 2008 | -536.97% | -46.77% |
| 2007 | -1,008.77% | -55.62% |
| 2006 | -2,273.03% | 0.00% |
| 2005 | 0.00% | 0.00% |
| 2004 | 0.00% | 0.00% |
| 2003 | 0.00% | 0.00% |
| 2002 | 0.00% | 0.00% |
| 2001 | 0.00% | 0.00% |
| 2000 | 0.00% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 17.03% | -99.26% |
US
|
|
| 17.86% | -99.22% |
IE
|
|
| 22.03% | -99.04% |
US
|
|
| 21.46% | -99.06% |
US
|
|
| 0.00% | - |
DE
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。